Stock BNN BRAIN BIOTECH AG
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases BRAIN Biotech AG

Equities

BNN

DE0005203947

Environmental Services & Equipment

Market Closed - Xetra
Other stock markets
 11:36:15 2025-01-23 am EST 		5-day change 1st Jan Change
3.240 EUR -0.61% Intraday chart for BRAIN Biotech AG -1.52% -8.73%
Jan. 14 BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024 CI
Dec. 12 BRAIN Biotech AG - Analyst/Investor Day

Press Releases

Search
See the results
DD: BRAIN Biotech AG: Adriaan Moelker, buy
Jan. 16
 EQ
BRAIN Biotech : Management Statement 12M 2023/24 (BRAIN IR AnalystCall12M 2023 24 final)
Jan. 15
 PU
Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
Jan. 15
 EQ
AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Jan. 07
 EQ
BRAIN Biotech AG Sharpens Focus on Profitable Growth
Dec. 12
 EQ
BRAIN Biotech : IR Presentation "Deutsches Eigenkapitalforum 2024"
Nov. 27
 PU
BRAIN Biotech : Management Statement Akribion Therapeutics Agreement
Nov. 27
 PU
BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
24-10-31
 EQ
BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
24-10-31
 EQ
BRAIN Biotech and Biodiscovery: Strategic partnership expands access to untapped enzymes for industrial application via MetXtra™
24-10-08
 PU
Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
24-10-03
 EQ
BRAIN Biotech : IR Presentation "Baader Investment Conference 2024"
24-09-26
 PU
BRAIN Biotech : Management Statement Royalty Purchase Agreement
24-09-22
 PU
BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
24-09-20
 EQ
BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
24-09-20
 EQ
BRAIN Biotech : Biocatalysts Ltd Launches Lipomod™ 70MDP - Setting A New Standard To Deliver Sustainable Solutions for Oleochemicals Industry with Maximal Production Efficiency
24-09-18
 PU
BRAIN Biotech : Investor Relations Presentation EF Autum Conference 2024
24-09-04
 PU
BRAIN Biotech : Management Statement 9M 2023/24
24-08-29
 PU
BRAIN Biotech : Quarterly Statement as of 30 June 2024 (9M)
24-08-29
 PU
BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year
24-08-29
 EQ
BRAIN Biotech : IR Presentation "Equity Forum German Fall Conference 2024"
24-08-28
 PU
BRAIN Biotech : launches the innovative technology platform MetXtra™ enabling unique enzyme solutions
24-08-22
 PU
BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes
24-05-29
 EQ
BRAIN Biotech : receives major milestone payment and stays on-track to achieve year end targets
24-05-28
 PU
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets 
24-05-28
 EQ
Become a member to access more news.
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNN Stock
  4. News BRAIN Biotech AG
  5. Press Releases